Skip to main content

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gupta's full profile

Already have an account?

  • Office

    1400 VFW Parkway
    Boston, MA 02132

Summary

  • Dr. Kalpana Gupta is an infectious disease specialist based in Boston, MA, with extensive experience in urinary tract infections. She completed her medical education at the Stony Brook University Health Sciences Center School of Medicine in 1991 and pursued residency and fellowship training at Beth Israel Deaconess Medical Center and the University of Washington. Dr. Gupta has contributed to the field through various publications, including studies on urinary tract infections, healthcare worker attitudes towards preoperative urine cultures, and sickness presenteeism during the COVID-19 pandemic. She is involved in clinical trials, such as one focusing on the optimal treatment for recurrent Clostridium difficile infections.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 1996 - 2000
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1995 - 1996
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1991 - 1994
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1991

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2003 - 2025
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Other

Press Mentions

  • Pfizer Dominates the COVID Drug Market. This Watertown Biotech Wants to Change That
    Pfizer Dominates the COVID Drug Market. This Watertown Biotech Wants to Change ThatNovember 9th, 2022
  • Boston Infectious Disease Specialists: Our New Year’s Resolutions
    Boston Infectious Disease Specialists: Our New Year’s ResolutionsDecember 31st, 2020
  • Landmark Study Suggests Cranberries Can Decrease Use of Antibiotics
    Landmark Study Suggests Cranberries Can Decrease Use of AntibioticsJune 16th, 2016